This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.
PHASE1
The purpose of this study is to estimate the safety and the efficacy of ant...
Status
Not Yet Recruiting
Location
State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Dermatology